Accumulations of mitochondrial DNA (mtDNA) mutations associated with aging are evident in multiple human tissues. The role of mtDNA mutations can be observed in an aging animal model such as homozygous knock-in PolgA mice, which have a large colonial expansion of mtDNA mutations. They develop reduced lifespan and premature onset of age-related phenotypes, that are also observed in clinical practice like mitochondrial aging acceleration with anti-retroviral therapy through clonal expansion of mtDNA mutations. These clonally expanded mtDNA mutations maintain transcription ability which could result in an accumulation of abnormal mitochondrial RNA (mtRNA) in the affected cells. Compensation-effect doctrine states that accumulated mtDNA mutations in the cell must reach a set threshold before they have a negative effect on cell function due to compensation effects from normal cellular mtDNA. In contrast to this theory, we suggest that an accumulation of aberrant mtRNA transcribed from mtDNA mutations negatively influences cellular function through complex internal and external mitochondrial pathways, and might be an important cause of aging and aging-associated diseases. 
Introduction
Nuclear and mitochondrial DNA are thought to be of separate evolutionary origin, with the mtDNA being derived from the circular genomes of the bacteria that were engulfed by the early ancestors of today's eukaryotic cells [1, 2] . Most proteins present in the mitochondria are coded by nuclear DNA, but the genes for some of them, are thought to have originally been of bacterial origin, having been transferred to the eukaryotic nucleus during evolution [3] . As a consequence of this transfer, mechanisms necessarily exist to coordinate and control the expression of the nuclear and mitochondrial genome's encoded genes in order to maintain and control cellular function [4, 5] . Because nuclear encoded MicroRNAs were isolated from mitochondria [6] and the nuclear-encoded 5S rRNA was identified as one of the most abundant RNAs in human mitochondria [7] , therefore, RNA import into mammalian mitochondria is considered essential for replication, transcription, and translation of the mitochondrial genome. On the other hands, deep sequencing of small RNAs reveals a considerable number of mitochondrial RNA-derived small RNAs appear at nuclear and cytoplasm [8] , some of which are regarded as mitochondrial original MicroRNAs [9] . It is also known that human mitochondrial tRNAMet can export to the cytoplasm where it associates with argonaute [10] , a catalytic component protein involved in silencing the RNA induction complex. More recently data also showed that nuclear localization of the mitochondrial long non-coding RNAs (ncRNAs) in normal and cancer cells [11] . These RNA from mitochondria should have role in maintain the normal function of cell. Indeed, transfer of mitochondrial DNA to the yeast nucleus remains an on-going process with mtDNA being used to repair double stranded breaks in yeast nuclear chromosomes under certain conditions [12] . A recent experiment showed that mitochondrial-nuclear DNA interactions contributing to the regulation of nuclear transcript levels, which are parts of the inter-organelle communication system in yeast [13] . Importantly, an experiment revealed that mitochondrial associate with P-bodies (cytoplasmic granules linked to mRNA decay storage and RNA interference), and modulation of microRNAmediated RNA interference. The depletion of P-bodies does not seem to affect mitochondria, nor the mitochondrial activity to be required for their contacts with P-bodies. However, inactivation of mitochondria leads to a strong decrease of miRNA-mediated RNAi efficiency, and to a lesser extent of siRNA-mediated RNAi [14] . Replication of nuclear and mitochondrial genomes is synchronized during cellular proliferation [15] . Increasing the amount of mitochondrial DNA accelerates overall cell proliferation and promotes nuclear DNA replication in a nutrient-dependent manner in yeast [16] . Mitochondria have a direct and specific role in enforcing a G1-S cell cycle checkpoint during periods of energy deprivation in multiple tissues of Drosophila [17] . Live-cell imaging and biochemical approaches demonstrate that mitochondria convert isolated fragmented elements into a hyperfused, giant network at G1-S transition; depolarizing mitochondria at early G1 prevent these changes causing blocked S phase progression. Conversely, inducing mitochondrial hyperfusion causes quiescent cells, maintained without growth factors, to begin replicating their DNA and coincides with a buildup of cyclin E [18] . This experiment disclosed that mitochondrial hyperfusion is a key to initiating the cell cycle. What is not known is what happened after mitochondrial hyperfusion? One possibility is that the giant voluminous mitochondrial network at G1-S permits some genetic material (for example, ncRNAs especially small RNA) out of mitochondria and into the nucleus, to initiate DNA replication, although this underlying mechanism has yet to be discovered. It is likely that crosstalk between nuclear and mitochondrial genomes occurring through the outflow of materials such as ncRNAs might be important in functional integrity of the cells.
Accumulation of mitochondrial DNA (mtDNA) mutations associated with aging is evident in multiple human tissues [19] . These clonal expansion mtDNA mutations maintain transcribe ability [20, 21] would result in an accumulation of unbalanced aberrant mitochondria RNA (mtRNA) in the affected cells. We suggest that an unbalanced accumulation of aberrant mtRNA transcribed from mtDNA mutations negatively influences cellular function through complex internal and external mitochondrial pathways, which might be important causes of aging and aging associated diseases.
Hypothesis
Accumulating of abnormal mitochondrial recombinants or other mtDNA mutations will transcribe aberrant mitochondrial RNA, which may implicate in cell aging and aging relative diseases through complex paths.
(a) Abnormal mtDNA recombinants or other mutations in the mitochondria will transcribe more 12S and 16S ribosomal RNA, which may accumulate in the mitochondria, and may interfere with mitochondrial protein folding. They could change the function of their enzyme/proteins by modification of their secondary structure, or initiate mitochondrial unfolded protein response (UPRmt) resulting in cellular apoptosis [22] . (b) Excessive mtRNA, especially ribosomal RNA and mitochondrial RNA transcribed from mtDNA recombinants or other mutations may be processed into small RNA, such as microRNA, that then negatively impact on transcriptional levels and post-transcriptional regulatory system of mitochondrial DNA. Additionally, these small mtRNA may also escape from the mitochondria, and be exported into the cytoplasm associated with the argonaute protein [10] , and may also enter the nucleus [11] where it can have a negative impact on the function of cells [23] .
Explanation for hypothesis
Accumulation of mitochondrial DNA mutations with aging are evidence from extensive research, these mutations are suggestion that might be involved in the pathological process of aging, and might be important causes of many aging-associated diseases(6;7). We note here that the estimates of less than 1% frequency rate of mtDNA deletions in aging tissues at the cellular level are based on scoring only one type of deletion ('common') and need to be revised. Combining direct sequencing of mtDNA from frozen brain tissue along with new DNA sequencing analysis software, for the first time, we provide a comprehensive assessment of mtDNA rearrangement events in aging cells. mtDNA rearrangement are rich in aging brain cells. The common mtDNA4977 deletion (8470-8482/ 13447-13459) was detected in samples, but the percentage was quite low when compared with the total number of deletions in each sample (1.5%). We calculated the rate by dividing the number of positive rearrangements by the coverage depth. The rate was 6.7% in aging brain tissues (average age 82, n = 12, unpublished data). High percentage of mitochondrial DNA recombinants occur at aging tissues would transcribe the aberrant mitochondrial RNA in the mitochondria of cells [24] .
A contemporary concept is that mitochondrial loss-of-function mutations must first reach a threshold level through clonal expansion before they can cause adverse effects. This is because there is functional complementation among different copies of mtDNA, in and between mitochondria in one cell (5) . This concept only considers one process: how to produce enough proteins for respiratory complexes of electron transport chain without affecting the rate of mitochondrial respiration or ATP synthesis in an individual cell. It ignores the fact that large amounts of unneeded mtRNA would be transcribed from mutations (especially deletions, which might be colonial expansion within cells with aging). Both strands of mtDNA are available for transcription. Heavy-strand transcription is initiated from two promoter sites, HSP1 and HSP2. The transcription of HSP1 covers the genes (12sRNA, 16sRNA), tRNA phenylalanine and tRNA valine. The HSP2 transcription produces a polycistronic molecule that corresponds to almost the entire heavy strand. It is thought that the initiation rate at HSP1 site is 20-fold higher than at HSP2, which results in more transcripts of 12sRNA, 16sRNA in the mitochondria (9) . Most recombinants such as deletions of mtDNA maintain the sequence for synthesizing 12sRNA/16sRNA and part of other mtDNA sequences as well. When they are transcribed, will produce large amounts of unbalanced mtRNA with excessive 12S rRNA, 16S rRNA, and parts of other mtRNA deletions depending on their location in the mitochondria of the implicated cells.
Mitochondria have dedicated machinery that functions to promote accurate protein folding and complex assembly within the organelle. It has been reported that mitochondrial 12S and 16S ribosomal RNA (rRNA) can fold chemically-denatured proteins and reactivate heat-induced aggregated proteins in vitro, and was proposed by authors that mitochondrial 12S and 16S ribosomal RNA may play an important role in protein folding in the mitochondria [25, 26] . We suggest that once redundant aberrant mtRNA accumulates in the matrix of the mitochondria, they may play a role in interfering with mitochondrial protein folding. Deficiencies of pyruvate dehydrogenase complex and ketoglutarate dehydrogenase [27] observed in AD brain may be caused by abnormal folding due to possible accumulation of ribosomal RNA. The redundant aberrant mtRNA might also initiate mitochondrial unfolded protein response (UPRmt) resulting in cellular apoptosis [22] .
Transcription and translation of the mtDNA, as well as the processing of the mitochondrial transcription unit, requires the involvement of several types of non-coding RNAs, which can be either mitochondrial-encoded or transcribed within the nucleus and subsequently relocated to the mitochondria. Argonaute proteins are the effector proteins of RNA interference (RNAi) and related silencing mechanisms that are mediated by small RNAs. Research has proven that there are localization of RNA interference components in the mitochondria, and reveals that there are a large number of MicroRNAs and Argonaute 2 protein within the mitochondria [9] . A comprehensive analysis of the human mitochondrial transcriptome shows that there are a rather large number of small RNAs transcribed from mitochondria genomic DNA; significantly, the majority (84%) of these small RNAs are derived from tRNA genes [28] . It is reasonable to speculate that aberrant accumulation of a large number of mitochondrial RNA because of mtDNA recombinant may interfere in full functionality of system involving in transcription and translation, and post-translation of mitochondrial DNA.
Mitochondria are dynamic organelles with continuing fusion and fission of procession in one cell. The old mitochondria must be destroyed through an auto phagocytic pathway which provides an excellent means for excess aberrant mtRNA to escape into the cytoplasm or nucleus. Since both strands of mtDNA have transcription activity, and the completed transcription units from opponent DNA may combine to form a double-stranded RNA helix. In fact, a couples non-coding mitochondrial RNA with long double-stranded structure have been detected in the mitochondria or nucleus of cells [11, 29] . Double-stranded RNA would be difficult to degrade by ribonuclease within the lysosome through a mitophagy pathway; however, there is a possibility that it may be processed by dicers or other similar endoribonuclease within the cytoplasm, and become a part of the iRNA system in the cells [10] ; participating in regulation of gene expression at the transcription level, and also in post transcriptional and translated levels. For example, there are various exported mitochondrial tRNA were detected in the cytosol in 293 cells, in which Ago2 was detected to be selectively bound to mitochondrial tRNA Met [10] . It also found that some of MicroRNAs map to the mitochondrial genome, might be originated from mitochondria [9] . We must keep in mind that the nucleus has numerous genomic sequences similar to the mitochondria, and many of them are located at introns, or promoter of nuclear genes [30] , and may be the potential target of these mitochondrial RNA original Micro RNA.
Support evidences
(1) Mitochondrial DNA polymerase subunit gamma (POLGA) homozygous knock-in mice express a proofreading deficient version of POLGA, which show increased mtDNA mutations including point mutations and deletions, in a 3 to 5-fold increase over controls in all tissues examined. The mutated mice develop age-related phenotypes [31, 32] . Evidence shows that increased mtDNA mutations are associated with premature aging in these mice [33] . An newer study created a congenic mouse model of Alzheimer's disease (AD), which provided the first in vivo evidence that mtDNA variants can have specific phenotypic effects on mitochondrial function, amyloid beta load/clearance, as well as cellular function [34] . Studies on a series of mouse mutants with mitochondrial DNA mutations present at birth indicate that these mutations can speed aging in animals even in the face of normal nuclear genomes [35] . In addition, mtDNA concentrations are low in cerebrospinal fluid in patients with preclinical AD or fully developed AD [36] . Role of mtDNA mutations in aging also observed in clinical practice such as mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mtDNA mutations [37] . All these studies suggest mitochondrial changes may work as a driving force, rather than a consequence, of the aging process and AD pathogenesis [38, 39] . (2) Functional abnormalities resulting from mtDNA in diseases can be demonstrated through the study of cybrids. Unique cybrid cell lines that model diseases' pathology were created by fusing mitochondrial DNA-free SH-SY5Y human neuroblastoma cells with platelet mitochondria from either diseases' patients or aged matched controls. A example from AD cybrid lines, which showed reduced cytochrome oxidase activity and increased oxygen radical production. These cells also exhibited reduced organelle movement, and produced substantially increased amounts of both intracellular and extracellular Ab relative to the control cybrid lines [40, 41] . Another example from cancer cybrid, which also revealed that altered cancer mitochondrial genome affect the respiratory chain function and oncogenic properties in vitro and in vivo [42] . Cybrids from both AD/cancer, and controls have the same nuclear genetic DNA background but differ in mtDNA. These differences have been ascribed to mtDNA variations within samples [43, 44] . We suggest unique mtDNA recombinants may be in the diseases' cybrid, which express aberrant mitochondria RNA work as causes of these unique pathologies occur at diseases. (3) Humanin is a peptide which is regarded as a neuro-protective factor [45] . The sequence of humanin mRNA reveals that it is derived from a portion of the mitochondrial MT-RNR2 gene (16sRNA). Yet, no mechanism has been demonstrated for this mRNA production from the mitochondria and translocation to the cytoplasm and extracellular space. However, electron microscopy demonstrated that the mitochondrial large ribosomal RNA in the pole plasm of Drosophila melanogaster, which is present outside the mitochondria and localized on the polar granules, has a role in the restoration of the pole cell-forming ability in Drosophila embryos; a couple of long double-stranded mitochondrial ncRNAs localized in the nucleus associated to heterochromatin provide another evidence that mtRNA might be out of mitochondria [11, 29] . The humanin mRNA is 1555 base pairs in length, and is a 100% match with mitochondrial DNA which makes it difficult to explain its origin as being from splicing of different mtDNA pseudogenes in the nucleus. Humanin should be regarded as an example of mitochondrial RNA that may be translated (although the underlying pathway needs to be explored) into peptide/protein by ribosomes in the cytoplasm when it enters into the cytosol.
Conclusion
Different original genomes combined and evolved into the eukaryotic cells we have today. Functional integrity of cells requires both nuclear and mitochondria genetic material for effective communication. ncRNA may have a key role in communication. Biological aging is the endogenous process of accumulative changes of molecular and cellular structure with the passage of time, which lead to deterioration and death of cells.
The mitochondrial theory of aging concludes that mitochondrial respiratory function declines with age to the point where energy needs go unmet leading to physiological senescence. Declining respiratory function may also generate more reactive oxygen species (ROS) due to dysfunctional respiratory enzyme complexes, setting up a vicious cycle of further damage to the respiratory machinery and in turn still more ROS generation [46] . However this theory cannot explain the complex pathological process of aging in cells, and the vicious cycle concept is in contradictions to results of aging animal model, which showed that pathogenesis of homozygous knock-in PolgA mutant mice is not associated with increased markers of oxidative stress or a defect in cellular proliferation, instead was correlated with the induction of apoptotic markers [47] . The aberrant mtRNA hypothesis might provide more reasonable alternative explain of complex pathological process of aging. The new concept that aberrant RNA from accumulating mtDNA mutations has a pathological role in aging may also provide a clue to explore the exact pathological mechanism of aging-associated diseases with complex pathological phenotypes. Parkinson's disease, for example, has high levels of mitochondrial DNA recombinants in the brain. Research on how these aberrant mtRNA transcribed from abnormal mtDNA recombinants in the brain may help us find the exact mechanism of Parkinson's disease.
Conflict of interest statement
None.
